证券代码：300829 证券简称：金丹科技 公告编号：2021-036 河南金丹乳酸科技股份有限公司 关于参加河南辖区上市公司 2021 年投资者网上集体接待日 活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，河南金丹乳酸科技股份有限公司定于 2021年6月8日（周二）16:00-17:20 参加在全景网举办的"真诚沟通 传递价值" 河南辖区上市公司2021年投资者网上集体接待日活动，本次活动将采用网络远程 的方式举行，投资者可登录"全景•路演天下"（ http://rs.p5w.net）参与本次互 动交流。 出席本次网上集体接待日活动的人员为：公司董事会秘书崔耀军先生（如有 特殊情况，参会人员将可能进行调整），欢迎广大投资者积极参与。 特此公告。 河南金丹乳酸科技股份有限公司 董事会 2021年6月2日 ...

Financial Performance - The company's operating revenue for Q1 2021 was CNY 319,492,683.60, representing a 56.88% increase compared to CNY 203,652,077.75 in the same period last year[8]. - The net profit attributable to shareholders decreased by 25.22% to CNY 27,906,648.99 from CNY 37,317,480.84 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was CNY 25,435,702.97, down 14.32% from CNY 29,688,232.50 in the previous year[8]. - Basic and diluted earnings per share were both CNY 0.25, down 43.18% from CNY 0.44 in the previous year[8]. - The company reported a total comprehensive income of CNY 27,074,734.84, down from CNY 36,824,559.80 in the previous year[47]. - Total comprehensive income for the first quarter was CNY 31,916,395.24, compared to CNY 38,870,272.50 in the previous period, indicating a decrease[51]. Cash Flow - The net cash flow from operating activities was CNY 26,185,385.55, a decline of 52.08% compared to CNY 54,638,715.90 in the same period last year[8]. - Cash inflow from operating activities totaled CNY 337,179,593.13, up from CNY 243,683,026.88 in the previous period, representing an increase of approximately 38.5%[54]. - Cash outflow for purchasing goods and services was CNY 261,811,905.24, compared to CNY 134,690,843.99 in the previous period, showing an increase of approximately 94.3%[54]. - Cash flow from investing activities resulted in a net outflow of CNY 34,725,192.87, slightly improved from a net outflow of CNY 36,106,247.31 in the previous period[54]. - Cash flow from financing activities showed a net outflow of CNY 2,119,367.64, an improvement from a net outflow of CNY 22,467,919.65 in the previous period[55]. - The ending balance of cash and cash equivalents was CNY 127,652,684.99, down from CNY 138,375,630.57 at the beginning of the period[55]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,775,918,607.97, an increase of 1.42% from CNY 1,751,131,954.37 at the end of the previous year[8]. - Total liabilities were CNY 412,463,438.05, a slight decrease from CNY 414,756,584.38, showing a reduction of approximately 0.6%[37]. - The company's equity attributable to shareholders increased to CNY 1,329,165,463.49 from CNY 1,301,347,038.61, reflecting a growth of about 2.1%[38]. - Current assets totaled CNY 555,210,068.73, slightly decreasing from CNY 558,211,562.97, indicating a decline of about 0.4%[35]. - Inventory increased significantly to CNY 165,884,641.08 from CNY 130,457,102.27, representing a growth of approximately 27.2%[35]. - Total equity increased to CNY 1,352,451,724.04 from CNY 1,320,535,328.80, indicating a growth of approximately 2.5%[45]. Operating Costs and Expenses - Operating costs rose to CNY 259.45 million, a 97.75% increase from CNY 131.20 million in the same period last year, primarily due to a significant rise in corn procurement prices[18]. - Research and development expenses increased by 69.65% to CNY 12.62 million, reflecting the company's increased investment in R&D[18]. - Operating costs amounted to CNY 293,851,986.51, compared to CNY 170,167,271.38 in the same period last year, reflecting a rise in costs[45]. - Research and development expenses rose to CNY 12,616,662.18, up from CNY 7,436,849.12, reflecting a 69.3% increase in investment in innovation[45]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,066[12]. - The largest shareholder, Zhang Peng, holds 32.69% of the shares, amounting to 36,906,000 shares, with 2,180,000 shares pledged[12]. Future Plans and Investments - The company plans to invest CNY 300 million in a project to produce 60,000 tons of biodegradable polyester and related products, enhancing its product line in biodegradable materials[23]. - The company plans to continue focusing on market expansion and product development to drive future growth[46]. Risks and Sensitivities - The company faces risks related to corn price fluctuations, which significantly impact production costs, as corn accounts for a large portion of the cost of lactic acid and its derivatives[20]. - Approximately 30% of the company's main business revenue comes from export sales, making it sensitive to fluctuations in the RMB/USD exchange rate[22].

Financial Performance - The company's operating revenue for 2020 was CNY 1,027,255,392.26, representing a 16.99% increase compared to CNY 878,107,136.71 in 2019[16] - The net profit attributable to shareholders for 2020 was CNY 119,629,812.60, a 3.84% increase from CNY 115,210,946.15 in 2019[16] - The net profit after deducting non-recurring gains and losses was CNY 105,681,353.25, which is a decrease of 4.52% compared to CNY 110,681,325.10 in 2019[16] - The net cash flow from operating activities was CNY 152,067,535.41, down 2.33% from CNY 155,692,960.05 in 2019[16] - The total assets at the end of 2020 were CNY 1,751,131,954.37, an increase of 44.37% from CNY 1,212,951,167.73 at the end of 2019[16] - The net assets attributable to shareholders at the end of 2020 were CNY 1,301,347,038.61, which is a 103.35% increase from CNY 639,959,035.77 at the end of 2019[16] - The basic earnings per share for 2020 were CNY 1.16, a decrease of 14.71% from CNY 1.36 in 2019[16] - The weighted average return on equity for 2020 was 11.28%, down from 19.78% in 2019, a decrease of 8.50%[16] - The total profit amounted to CNY 129.06 million, reflecting a year-on-year growth of 6.70%[54] - The company reported a net profit attributable to shareholders of 30% for the year 2020[134] Revenue and Sales - The company reported a total revenue of CNY 306,329,824.96 in Q4 2020, which was the highest quarterly revenue for the year[18] - Revenue from lactic acid amounted to ¥694,909,902.79, with a growth of 21.16% compared to the previous year[72] - Domestic revenue was ¥758,020,960.79, reflecting a 21.05% increase year-on-year, while international revenue was ¥269,234,431.47, up by 6.88%[72] - The gross profit margin for lactic acid was 22.76%, down by 7.91% from the previous year[72] - The company's top five customers contributed ¥70,012,700, accounting for 6.82% of total sales revenue[64] - The sales revenue from the top five customers totaled CNY 194,579,282.12, accounting for 18.94% of the annual total sales[79] Investment and Financing - The company raised a total of RMB 637.6 million through its initial public offering, with a net amount of RMB 541.7 million after deducting related issuance costs[100] - The company has a total of RMB 535.9 million in planned investments across various projects, with a cumulative actual investment of RMB 266.8 million[96] - The company confirmed the feasibility of starch sugar production technology for lactic acid[83] - The company plans to complete the "Annual Production of 50,000 Tons of High Purity L-Lactic Acid Project" by October 2021, with an investment of 30,906 million RMB[104] - The company will implement measures to enhance performance and stabilize stock prices through cost-cutting and limiting executive compensation[135] Research and Development - The company holds 35 invention patents and has established several national and provincial research centers to enhance its R&D capabilities[49] - The company’s focus on R&D aims to develop efficient, energy-saving, and environmentally friendly production technologies for lactic acid and its derivatives[25] - The company's research and development expenses increased by 24.37% to CNY 41,429,076.89 in 2020, up from CNY 33,311,708.63 in 2019[81] - The number of R&D personnel increased to 143 in 2020, accounting for 14.03% of the total workforce[83] - The company aims to increase its R&D investment in lactic acid and related products to strengthen its market competitiveness[136] Market Position and Strategy - The company is a leading enterprise in the research, production, and sales of lactic acid and its derivatives, with products sold in over 80 countries and regions globally[25] - The company is positioned to benefit from increasing demand for biodegradable plastics as regulations against plastic pollution are enforced[43] - The lactic acid market in China is expected to grow steadily, with food and beverage applications currently accounting for about 70.40% of consumption[41] - The company aims to become a leader in the global lactic acid industry, focusing on biotechnology and new materials as strategic growth areas[111] - The company plans to enhance inventory management, customer resource maintenance, market expansion, quality control, and new product development to improve its resilience against operational risks[136] Profit Distribution and Shareholder Returns - The company proposed a profit distribution plan for 2020, distributing a cash dividend of 2 CNY per 10 shares, totaling 22,581,818.40 CNY[127] - The cash dividend represents 18.88% of the net profit attributable to shareholders for 2020[131] - The company has a policy that cash dividends should constitute at least 20% of the profit distribution in the growth stage[126] - The company plans to distribute at least 10% of the annual distributable profit in cash dividends, with a cumulative cash distribution over the last three years not less than 30% of the average annual distributable profit during that period[139] - The company will implement a stable dividend distribution policy post-IPO, ensuring reasonable returns to investors while considering sustainable development[138] Environmental and Social Responsibility - The company contributed over 8 million RMB to local poverty alleviation efforts over the past three years, including over 10 million RMB in 2020 for COVID-19 prevention and other public health initiatives[169] - The company is classified as a key pollutant discharge unit by environmental protection authorities[171] - The company implemented advanced anaerobic and aerobic biological treatment technologies for wastewater, ensuring compliance with discharge standards[173] - The company has committed to improving product quality and reducing production consumption as part of its social responsibility initiatives[169] Corporate Governance and Compliance - The company has engaged Da Hua Accounting Firm for auditing services, with a fee of 650,000 RMB, and has maintained this auditor for two consecutive years[145] - The company has not reported any significant changes in the scope of the consolidated financial statements compared to the previous year[144] - The company has not experienced any bankruptcy reorganization or significant litigation during the reporting period[147][148] - The company has not engaged in any major related party transactions during the reporting period[153][154][155][156][157] - The company has disclosed all related party transactions in accordance with legal and regulatory requirements[134]

Financial Performance - Operating revenue for the reporting period was CNY 248,085,113.29, an increase of 8.91% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 37,791,469.81, up 2.44% year-on-year[7] - Net profit after deducting non-recurring gains and losses decreased by 23.26% to CNY 28,392,263.89[7] - Basic earnings per share decreased by 25.00% to CNY 0.33[7] - The weighted average return on equity was 2.99%, down 3.15% from the previous year[7] - Total operating revenue for the third quarter was CNY 248,085,113.29, an increase from CNY 227,797,894.11 in the previous period, representing a growth of approximately 8.4%[34] - Total operating costs amounted to CNY 216,184,435.49, up from CNY 192,451,120.02, indicating an increase of about 12.3%[35] - Net profit for the period reached CNY 37,597,309.27, compared to CNY 35,283,086.93 in the same period last year, reflecting a growth of approximately 6.5%[36] - The company reported a total comprehensive income of CNY 37,619,875.51, an increase from CNY 35,081,489.20 in the prior period, reflecting a growth of approximately 7.2%[37] - The company achieved a total comprehensive income of CNY 102,187,042.79, compared to CNY 92,264,274.56, representing an increase of 10.0%[45] Assets and Liabilities - Total assets increased by 39.13% to CNY 1,687,560,097.79 compared to the end of the previous year[7] - The company's total assets increased significantly, with construction in progress rising by 44.67% to ¥326,125,279.75 due to ongoing projects[15] - As of September 30, 2020, total current assets increased to ¥599,407,109.24 from ¥214,517,624.25 as of December 31, 2019, representing an increase of approximately 179.5%[26] - Total non-current assets reached ¥1,088,152,988.55, up from ¥998,433,543.48, which is an increase of about 9.0%[27] - The company's total liabilities decreased to CNY 351,765,737.84 from CNY 491,504,370.83, a reduction of about 28.5%[35] - The total assets of the company reached CNY 1,655,256,914.42, up from CNY 1,147,748,907.26, indicating an increase of about 44.3%[35] - The total amount of other receivables stands at CNY 34,487,632.60, which could indicate potential liquidity issues[62] Cash Flow - Net cash flow from operating activities increased by 87.28% to CNY 47,604,539.92[7] - The net cash flow from operating activities rose by 36.52% to ¥134,780,242.11, driven by increased sales revenue[16] - The net cash flow from operating activities was CNY 134,780,242.11, compared to CNY 98,729,116.61 in the previous year, reflecting a growth of 36.48%[51] - The company reported a net cash outflow from investing activities of CNY 448,065,097.87, which is a significant increase from CNY -126,836,544.97 in the same period last year[52] - The company's cash and cash equivalents at the end of the period were ¥40,521,002.80, an increase from ¥25,435,474.46 at the end of the previous period[55] Shareholder Information - Net assets attributable to shareholders rose by 100.78% to CNY 1,284,879,739.50 year-on-year[7] - The total number of ordinary shareholders at the end of the reporting period was 13,471[10] - The company's equity attributable to shareholders rose to ¥1,284,879,739.50 from ¥639,959,035.77, representing an increase of about 100.5%[29] Expenses - Management expenses rose by 41.05% to ¥59,302,168.95, mainly due to significant repair costs for equipment[16] - The company reported a 968.27% increase in non-operating expenses to ¥10,265,000.00, linked to substantial donations made during the pandemic[16] - Research and development expenses for the quarter were CNY 11,890,038.26, up from CNY 9,042,784.69, representing a growth of about 31.3%[35] - Financial expenses totaled CNY 10,461,675.35, compared to CNY 9,788,100.65, indicating an increase of 6.9%[44] - Tax expenses for the period were CNY 12,334,445.22, compared to CNY 8,400,713.75, an increase of 46.0%[44] Government Support and Investments - The company received government subsidies amounting to CNY 21,418,385.51, primarily from technology special subsidies and listing rewards[8] - The company reported a 437.78% increase in investment income to ¥1,795,513.18, attributed to cash management of idle funds and dividends from its stake in Zhongyuan Bank[16] - The company received CNY 600,000,000.00 from investment recoveries, indicating active management of its investment portfolio[52] - The company’s long-term investments included a cash payment of ¥950,000,000.00, compared to ¥11,600,000.00 in the previous period, indicating a strategic focus on growth[53] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[30] - The company has not disclosed any performance forecasts for the upcoming reporting period[18] - The report indicates that the third-quarter financials were not audited, which may affect the reliability of the data presented[64] - The company has not reported any new product developments or market expansion strategies in this quarter[64]

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 472,840,454.01, representing a 14.50% increase compared to CNY 412,947,620.61 in the same period last year[19]. - The net profit attributable to shareholders was CNY 65,387,653.13, up 13.81% from CNY 57,455,286.77 year-on-year[19]. - The net profit after deducting non-recurring gains and losses was CNY 63,529,213.48, reflecting a significant increase of 29.55% compared to CNY 49,039,378.21 in the previous year[19]. - The net cash flow from operating activities was CNY 87,175,702.19, an increase of 18.91% from CNY 73,309,733.56 in the same period last year[19]. - Basic earnings per share were CNY 0.70, a slight increase of 2.94% from CNY 0.68 in the same period last year[19]. - The weighted average return on equity was 7.66%, down from 10.38% in the previous year, indicating a decrease of 2.72%[19]. - The company reported a total of CNY 1,858,439.65 in non-recurring gains and losses during the reporting period[24]. - The company achieved historical highs in both sales volume and profit, despite facing challenges such as the global COVID-19 pandemic and increased competition[53]. - The company’s lactic acid sales volume increased significantly due to the impact of the ban on plastic and antibiotics, as well as product structure upgrades[66]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 1,703,034,231.23, a 40.40% increase from CNY 1,212,951,167.73 at the end of the previous year[20]. - The net assets attributable to shareholders increased by 94.87% to CNY 1,247,072,473.33 from CNY 639,959,035.77 at the end of the previous year[20]. - The company's total liabilities decreased to CNY 420,292,118.29 from CNY 536,458,006.76, a reduction of approximately 21.7%[174]. - Owner's equity surged to CNY 1,282,742,112.94, up from CNY 676,493,160.97, reflecting an increase of around 89.3%[174]. - Cash and cash equivalents saw a substantial rise to CNY 433,383,126.17 from CNY 26,165,875.93, indicating a growth of over 1531%[176]. - Accounts receivable decreased to CNY 59,118,165, accounting for 3.47% of total assets, down by 2.62% from the previous year[82]. - Inventory increased to CNY 91,143,760, representing 5.35% of total assets, a decrease of 1.53% compared to the previous year[82]. - Fixed assets amounted to CNY 567,105,899, making up 33.30% of total assets, down by 13.51% from the previous year[82]. Research and Development - The company’s R&D investment rose to CNY 18.20 million, a 21.07% increase compared to the previous year[75]. - The company has established partnerships with universities for R&D in new products and processes, aiming to enhance the lactic acid industry chain[104]. - The company plans to increase R&D investment to optimize production processes, reduce costs, and launch new products to maintain its competitive advantage and market position[105]. Market and Products - The company is a high-tech enterprise focused on the research, production, and sales of lactic acid and its derivatives, with products sold in over 80 countries and regions globally[28]. - The main products include lactic acid, sodium lactate, and calcium lactate, widely used in food, feed, biodegradable materials, industrial applications, and pharmaceuticals[30]. - The company adopts a market-oriented production model, determining production plans based on customer demand and market conditions[44]. - The demand for biodegradable materials is expected to grow rapidly, driven by environmental policies and increasing consumer awareness, which will boost lactic acid consumption[55]. - The company has a production capacity of 128,000 tons of lactic acid and its derivatives, holding over 60% market share in the domestic market, positioning it as a leading enterprise in the industry[57]. Financial Management - The company has implemented a cost control system that rewards departments for lower material consumption and penalizes for exceeding set targets[48]. - The company plans to use idle raised funds for cash management, with a limit of 350 million RMB for investments in principal-protected financial products, which can be rolled over within 12 months[95]. - The company has not engaged in any major asset or equity sales during the reporting period[100][101]. - The company has not reported any changes in the use of raised funds or any issues related to the disclosure of raised funds[96][98]. Environmental Compliance - The company has implemented advanced anaerobic and aerobic biological treatment technologies for wastewater management, ensuring compliance with discharge standards[136]. - Total emissions of nitrogen oxides were recorded at 9.674 tons per year, with no exceedance of emission standards[135]. - The company adheres to strict environmental monitoring regulations and engages third-party testing for pollutant emissions[139]. - The company has established an emergency response plan for environmental incidents, registered with the local ecological environment bureau[138]. Shareholder Information - The company completed its initial public offering of 28.3 million shares, increasing total shares from 84,609,092 to 112,909,092[147]. - The earnings per share after the share issuance is reported at 0.98 RMB per share[150]. - As of June 30, 2020, the total number of common shareholders was 14,643[154]. - The largest shareholder, Zhang Peng, holds 32.69% of the shares, totaling 36,906,000 shares[154]. Miscellaneous - The company has not distributed cash dividends or bonus shares for the half-year period and does not plan to increase capital through reserves[112]. - There were no significant lawsuits or arbitration matters during the reporting period[117]. - The half-year financial report has not been audited[115]. - The company has not engaged in any major related party transactions during the reporting period[123].